Economic evaluations of adjuvant trastuzumab were reviewed. Three primary shortcomings were identified including incorporation of local data and estimation and representation (visual) of decision uncertainty.
Ilia L. Ferrusi, PhD(c)
Advertisement
Articles by Ilia L. Ferrusi, PhD(c)
Advertisement
Latest Updated Articles
- Do Economic Evaluations of Targeted Therapy Provide Support for Decision Makers?
Published: May 17th 2011 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Government Shutdown Could Disrupt Health Care Access
2
Maternal, Child Mortality Higher in the US Compared With Majority of High-Income Countries
3
Colon Cancer Recurrence Risk Nearly Gone After 6 Years, Study Reveals
4
Lurbinectedin Combo Approved by FDA for Extensive-Stage Small Cell Lung Cancer
5
